New Drug Approvals
@DrugscomNewGet the latest new drug approvals issued by the FDA and published on http://t.co/Z3IRapL5eR.
Similar User
@DrugscomAlerts
@DubhDonald
@Drugscom
@KKIASA
@CarterCenter
@MedscapePharm
@fenice
@SGS_SA
@GSK
@fwpharma
@GreenJournal
@OPSOMSMexico
@Intertek
@DosingMatters
@OGDiscoveryDev
FDA Approves #Revuforj (revumenib) for the Treatment of Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation drugs.com/newdrugs/fda-a…
FDA Approves #Danziten (nilotinib) Tablets, the First and Only Nilotinib With No Mealtime Restrictions drugs.com/newdrugs/fda-a…
FDA Approves #Kebilidi (eladocagene exuparvovec-tneq) Gene Therapy for the Treatment of AADC Deficiency drugs.com/newdrugs/fda-a…
FDA Approves #Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia drugs.com/newdrugs/fda-a…
FDA Approves #Emrosi (minocycline hydrochloride) for the Treatment of Rosacea drugs.com/newdrugs/fda-a…
FDA Approves #Orlynvah (sulopenem etzadroxil and probenecid) for the Treatment of Uncomplicated Urinary Tract Infections drugs.com/newdrugs/fda-a…
U.S. FDA Approves Pfizer’s RSV Vaccine #Abrysvo for Adults Aged 18 to 59 at Increased Risk for Disease drugs.com/newdrugs/u-s-f…
#Botox Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands) drugs.com/newdrugs/botox…
FDA Approves #Lumryz (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy drugs.com/newdrugs/avade…
FDA Approves #Vyloy (zolbetuximab-clzb) for the Treatment of Advanced Gastric and GEJ Cancer drugs.com/newdrugs/fda-a…
FDA Approves #Vyalev (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease drugs.com/newdrugs/fda-a…
FDA Approves #Imuldosa (ustekinumab-srlf), a Biosimilar to Stelara drugs.com/newdrugs/fda-a…
FDA Approves #Hympavzi (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors drugs.com/newdrugs/fda-a…
FDA Approves #Itovebi (inavolisib) for the Combination Treatment of Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation drugs.com/newdrugs/fda-a…
#Dupixent Approved in the US as the First-Ever Biologic Medicine for Patients with COPD drugs.com/newdrugs/dupix…
FDA Approves #Otulfi (ustekinumab-aauz), a Biosimilar to Stelara drugs.com/newdrugs/fda-a…
FDA Approves #Flyrcado (flurpiridaz F 18) Radioactive Diagnostic for Enhanced Diagnosis of Coronary Artery Disease drugs.com/newdrugs/fda-a…
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults drugs.com/newdrugs/u-s-f…
Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis drugs.com/newdrugs/fasen…
UCB announces U.S. FDA approvals for Bimzelx (bimekizumab-bkzx) for the treatment of psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis drugs.com/newdrugs/ucb-a…
United States Trends
- 1. #AskShadow 3.150 posts
- 2. GOTY 45,1 B posts
- 3. Sean Duffy 3.792 posts
- 4. #AskSonic N/A
- 5. Mika 114 B posts
- 6. Balatro 24,7 B posts
- 7. San Marino 44,2 B posts
- 8. Elden Ring 33,1 B posts
- 9. Katie Hobbs 11,4 B posts
- 10. #TheGameAwards 55,9 B posts
- 11. Mixon 2.786 posts
- 12. Morning Joe 94,4 B posts
- 13. Bakkt 14,6 B posts
- 14. #TheFive N/A
- 15. Ichiro 5.163 posts
- 16. #ysltrial 4.302 posts
- 17. Shadow of the Erdtree 12,7 B posts
- 18. SOTE 4.340 posts
- 19. Deciding 22,6 B posts
- 20. Metaphor 28,7 B posts
Who to follow
-
FDA Drug Alerts
@DrugscomAlerts -
Lord Inquisitor Torquemada Coteaz
@DubhDonald -
Drugs.com
@Drugscom -
RUH |مطار الملك خالد
@KKIASA -
The Carter Center
@CarterCenter -
Medscape Pharmacists
@MedscapePharm -
🜁🜄 Alchemical Tarot 🜂🜃
@fenice -
SGS
@SGS_SA -
GSK
@GSK -
FirstWord Pharma
@fwpharma -
Neurology Journal
@GreenJournal -
OPS/OMS México
@OPSOMSMexico -
Intertek
@Intertek -
Amit Pai
@DosingMatters -
Discovery & Development by Oxford Global
@OGDiscoveryDev
Something went wrong.
Something went wrong.